Three variants in the nicotinamide adenine dinucleotide phosphate oxidase complex are associated with HCV-related liver damage. (scientific article published on 23 October 2017)

Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox

Q24291589

The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts

Q26766479

Hepatitis C virus: A time for decisions. Who should be treated and when?

Q26768274

Role of NADPH oxidases in the redox biology of liver fibrosis

Q26800143

Natural compounds as modulators of NADPH oxidases

Q26829513

Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence

Q27488844

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

Q27860991

NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2

Q28247419

Epidemiology of viral hepatitis and hepatocellular carcinoma

Q29617918

Histological grading and staging of chronic hepatitis

Q29619625

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

Q29619627

A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity

Q33300467

Role of the NADPH Oxidases DUOX and NOX4 in Thyroid Oxidative Stress

Q33597583

Role of NADPH oxidases in liver fibrosis

Q33632736

Epidemiology and natural history of hepatitis C virus infection

Q33948292

Trends in waiting list registration for liver transplantation for viral hepatitis in the United States

Q34021608

Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells.

Q34024112

Epigenetic silencing of dual oxidase 1 by promoter hypermethylation in human hepatocellular carcinoma.

Q34178494

Toward a more accurate estimate of the prevalence of hepatitis C in the United States

Q34484872

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression

Q34787367

Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection

Q35121963

Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase

Q35673745

Association between NCF4 rs4821544T/C polymorphism and inflammatory bowel disease risk in Caucasian: a meta-analysis

Q35750595

NADPH oxidases: an overview from structure to innate immunity-associated pathologies

Q36302873

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

Q36346436

The combination of three molecular markers can be a valuable predictive tool for the prognosis of hepatocellular carcinoma patients.

Q36799987

HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection

Q36940140

A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.

Q37381703

Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail?

Q37616153

The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States

Q38062121

HCV and oxidative stress in the liver.

Q38077447

Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations

Q38157936

Nox/Duox Family of NADPH Oxidases: Lessons from Knockout Mouse Models

Q38727867

HCV core protein uses multiple mechanisms to induce oxidative stress in human hepatoma Huh7 cells.

Q38868301

NADPH oxidase DUOX1 and DUOX2 but not NOX4 are independent predictors in hepatocellular carcinoma after hepatectomy.

Q39474147

A Founder Effect of c.257 + 2T > C Mutation in NCF2 Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients

Q40661603

Dual oxidase 1: A predictive tool for the prognosis of hepatocellular carcinoma patients

Q40701503

NADPH Oxidase 1 and NADPH Oxidase 4 Have Opposite Prognostic Effects for Patients with Hepatocellular Carcinoma after Hepatectomy

Q40966286

Oxidative stress response in patients infected by diverse hepatitis C virus genotypes.

Q41411297

The NOD2insC polymorphism is associated with worse outcome following ileal pouch-anal anastomosis for ulcerative colitis

Q43727523

Progression of fibrosis in chronic hepatitis C.

Q44269259

Four different NCF2 mutations in six families from Turkey and an overview of NCF2 gene mutations.

Q45923034

Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort

Q46518390

Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.

Q46709785

Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase

Q47900889

Gene expression differences in nitric oxide and reactive oxygen species regulation point to an altered innate immune response in chronic rhinosinusitis.

Q54284529

A novel mutation in NCF2 associated with autoimmune disease and a solitary late-onset infection.

Q54790199

Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation.

Q55036226

Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C

Q61854129

"Immune activation, aging and gender" and progression of liver disease

Q83819439

P433

issue

P921